COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human test of experimental drug for deadly sepsis complication
Disease control Recruiting nowThis early-stage study is testing the safety of a new drug called BAY 3389934 for people with sepsis-induced coagulopathy, a dangerous condition where severe infection causes abnormal blood clotting. Researchers will give the drug to 36 hospitalized ICU patients, starting with lo…
Matched conditions: COAGULOPATHY
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Race against time: new powder vs. old frozen blood product to save trauma patients
Disease control Recruiting nowThis large trial aims to find the best way to replace a key blood clotting factor (fibrinogen) in adults with severe traumatic injuries and major bleeding. It will compare a fast-acting powder (fibrinogen concentrate) that can be mixed at the bedside against the standard frozen b…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Faster test for Kids' bleeding emergencies under study
Knowledge-focused Recruiting nowThis study aims to see if a new, faster blood clotting test works properly for children. Researchers will collect a small blood sample from 125 children having planned surgery to find out what normal results look like for them. The goal is to gather information that could help do…
Matched conditions: COAGULOPATHY
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC